The post‐therapeutic course was good in those patients in whom the prostate atrophied, and when this was combined with an absence of detectable cancer cells, the post‐therapeutic course was excellent. Many patients who experienced only general improvement or no change in prostate size after ...
Measure the Errors of Treatment Set-Ups of Prostate Cancer Patient Using Electronic Portal Imaging Device (EPID) The purpose of this work was the determination of the set-up errors for Prostate cancer patients by using electronic portal imaging device (EPID) [14], as ... MA Morsy,AR Ahmed...
Prostate IMRT : Promises and Problems Introduction Prostate is one of the treatment sites that is well suited for IMRT. For localized prostate cancer radiation therapy it is one of the effective modalities. However, radiation induced complications such as, urinary incontinen... C Burman,D. M. ...
Two roads to the same end. Cancer 1988; 61(11):2153-60.Hanks, G. E. Radical prostatectomy or radiation therapy for early prostate cancer. Two roads to the same end. Cancer 61:2153-2160: 1988.Hanks GE. Radical prostatectomy or radiation therapy for early prostate cancer: Two roads to...
Minesh Mehta, MD, deputy director, chief, Radiation Oncology, Miami Cancer Institute, Baptist Health, discusses recent advancements in in radiation therapy for patients with prostate cancer, particularly noting the benefits and significance of lutetium Lu 177 vipivotide tetraxetan (Pluvicto; formerly 17...
Tumors of the pelvic organs (ie, prostate, bladder, colon, rectum) are common in men, constituting 43% of expected new cancer diagnoses for 2024. [1] In women, cancer of the colon and rectum, bladder, and genital tract (uterus, ovary, and vagina/vulva) are expected to make up 21% ...
Although in use for over 40 years, proton beam therapy for prostate cancer has only recently come under public scrutiny, due to its increased cost compared to other forms of treatment. While the last decade has seen a rapid accumulation of evidence to suggest that proton beam therapy is both...
The probability that... GL Lu-Yao,AL Potosky,PC Albertsen,... - 《J Natl Cancer Inst》 被引量: 578发表: 1996年 Surrogate End Point for Prostate Cancer-Specific Mortality After Radical protatectomy of Radiation Therapy. Surrogate end point for prostate cancer-specific mortality after radical ...
Defining the appropriate radiation dose for pretreatment PSA Յ 10 ng/mL prostate cancer. Int J Radiat Oncol Biol Phys 2000;47(3):649 - 654.Pinover WH, Hanlon AL, Horwitz EM, Hanks GE. Defining the appropriate radiation dose for pretreatment PSA Ն 10 ng/mL prostate cancer. Int J ...
Risk of secondary malignancy following radiation therapy for prostate cancer Article Open access 16 November 2023 A national observation study of cancer incidence and mortality risks in type 2 diabetes compared to the background population over time Article Open access 15 October 2020 Validation ...